Xeris Biopharma  Inc. logo

Xeris Biopharma Inc.

XERS | NASDAQ
Chart Builder DCF Calculator
$8.81
+$0.01 (+0.11%)
Sep 22, 2026, 1:32 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
111.04M 71.62M 67.45M 121.97M 67.27M 37.6M
Short-Term Investments
n/a n/a 5M n/a 35.16M 96.19M
Long-Term Investments
n/a 4.12M n/a n/a n/a n/a
Other Long-Term Assets
5.22M -4.81M 4.54M 4.73M 829K 232K
Receivables
51.05M 40.42M 39.2M 30.83M 17.46M 6.88M
Inventory
68.67M 48.18M 38.84M 24.74M 18.12M 8.35M
Other Current Assets
9.55M 7.45M 5.78M 9.29M n/a n/a
Total Current Assets
240.31M 167.66M 156.26M 186.82M 142.6M 152.21M
Property-Plant & Equipment
27.06M 28.21M 29.18M 9.51M 6.63M 6.71M
Goodwill & Intangibles
110.94M 121.78M 132.62M 143.47M 154.31M n/a
Total Long-Term Assets
143.21M 155.4M 166.34M 157.7M 161.77M 6.94M
Total Assets
383.53M 323.06M 322.6M 344.52M 304.36M 159.15M
Account Payables
3.08M 2.29M 11.57M 4.61M 8.92M 3.12M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
6.23M 15.1M n/a n/a n/a n/a
Other Current Liabilities
100.27M 39.75M 51.43M 27.23M 25.63M 11.2M
Total Current Liabilities
109.57M 100.44M 95.19M 73.62M 79.04M 28.21M
Long-Term Debt
31.53M 217.01M 190.93M 187.08M 88.07M 87.02M
Other Long-Term Liabilities
228.73M 1.97M 6.23M 25.72M 37.08M 10.16M
Total Long-Term Liabilities
260.26M 252.23M 234.19M 225.71M 130.09M 97.18M
Total Liabilities
369.84M 352.68M 329.38M 299.34M 209.13M 125.39M
Total Debt
37.76M 271.45M 229.19M 198.06M 88.07M 87.02M
Book Value
13.69M -29.62M -6.78M 45.19M 95.23M 33.76M
Book Value Per Share
0.08 -0.20 -0.05 0.33 1.21 0.79
Common Stock
17K 15K 14K 14K 13K 6K
Retained Earnings
-671.31M -671.86M -617.03M -554.77M -460.11M -337.39M
Comprehensive Income
-25K -25K -25K -23K -31K 6K
Shareholders Equity
13.69M -29.62M -6.78M 45.19M 95.23M 33.76M
Total Investments
n/a 4.12M 5M n/a 35.16M 96.19M

© 2026 bestshares.com. All rights reserved.